表紙
市場調查報告書
商品編碼
1027551

全球鐮狀細胞治療市場:按治療方式(骨髓移植、輸血、藥物治療)、最終用戶(醫院、專科診所等)、地區(2021-2027)預測

Global Sickle Cell Treatment market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計在 2021-2027 年期間,全球鐮狀細胞療法市場將以超過 13% 的健康增長率增長。

鐮狀細胞病是一類導致血紅蛋白(一種攜帶含氧血液的分子)受損的疾病。在患有這種疾病的患者中發現鐮狀或新月形變形的紅細胞。鐮狀細胞病的症狀通常在兒童早期開始並持續到青春期。隨著紅細胞形狀的改變,它們可能會過早被破壞,導致貧血。治療鐮狀細胞性貧血的目的是減輕不適、減輕疼痛和預防併發症。一些青少年接受藥物治療和輸血治療。

市場受到越來越多的研發活動和鐮狀細胞病日益流行的推動。例如,根據美國國家衛生研究所的數據,全世界超過 90% 的鐮狀細胞病患者生活在三個國家。在尼日利亞、印度和剛果民主共和國三個國家,鐮狀細胞病患者人數已達到人口的2%,攜帶率(鐮狀細胞性狀)高達10%∼30% . 我是。然而,高昂的處理成本可能會阻礙 2021-2027 預測期內的市場增長。

本報告調查了全球鐮狀細胞療法市場,並提供了市場概況、治療方式趨勢、最終用戶、地區以及進入市場的公司概況。

目錄

第 1 章執行摘要

第二章全球鐮狀細胞療法市場的定義和範圍

第 3 章全球鐮狀細胞療法市場機制

  • 鐮狀細胞療法市場影響分析(2019-2027)

第 4 章全球鐮狀細胞治療市場行業分析

  • 波特的 5 力模型
  • PEST 分析
  • 招商招商模式
  • 分析師建議和結論

按治療方式分列的第 5 章全球鐮狀細胞治療市場

  • 市場快照
  • 按治療方式劃分的全球鐮狀細胞治療市場:性能-潛力分析
  • 按治療方式對全球鐮狀細胞療法市場的估計和預測:2018-2027(10 億美元)
  • 鐮狀細胞療法市場,細分市場分析
    • 輸血
    • 骨髓移植
    • 藥物治療

最終用戶第 6 章全球鐮狀細胞治療市場

  • 市場快照
  • 按最終用戶劃分的全球鐮狀細胞療法市場:性能-潛力分析
  • 全球鐮狀細胞治療市場估計和預測,按最終用戶:2018-2027(10 億美元)
  • 鐮狀細胞療法市場,細分市場分析
    • 醫院
    • 專科診所
    • 其他

第 7 章全球鐮狀細胞治療市場,區域分析

  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他領域

第8章衝突信息

  • 頂級市場策略
  • 公司簡介
      Quanqii lian zh
    • Bristol Myers Squibb Co.
    • Global Blood Therapeutics Inc.
    • Bluebird Biotechnology
    • F.Hoffmann-La Roche
    • Emmaus Medical Inc.
    • Eli-Lilly and Co.
    • Baxter Inc.
    • Medunik USA.Inc.
    • Addmedica Inc.
    • Glycomimetics Inc

第9章 調查流程

目錄

Global Sickle Cell treatment Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2021-2027. Sickle cell disease is a category of diseases that impair hemoglobin, the molecule that transports oxygenated blood. A deformed red blood cell with the shape of a sickle or crescent is found in people with this disease. Symptoms of sickle cell disease generally begin in early childhood and continue throughout adolescence. Red blood cells break down prematurely as they alter form, which can cause anaemia. The aim of sickle cell anaemia treatment is to reduce discomfort, relieve pain, and prevent complications. Some adolescents and teens are treated with medications and blood transfusions. The market is driven by the increasing research and development activity and increasing prevalence of sickle cell disease. For instance, as per the National Health Institute, over 90% of the world's SCD population resides in three countries: Nigeria, India, and the Democratic Republic of Congo, where the disease affects up to 2% of the population and the carrier prevalence rate (sickle cell trait) is as high as 10% to 30%. However, high cost of treatments may impede market growth over the forecast period of 2021-2027.

Geographically, the sickle cell treatment market in North America is dominated by the United States, which is the market's biggest contributor. Improved access to SCD treatment and potential pipeline medicines are attributed with the region's growth. The substantial government support in the United States will help promote the market's healthy growth.

Major market player included in this report are:

Bristol Myers Squibb Co.

Global Blood Therapeutics Inc.

Bluebird Biotechnology

F.Hoffmann-La Roche

Emmaus Medical Inc.

Eli-Lilly and Co.

Baxter Inc.

Medunik USA.Inc.

Addmedica Inc.

Glycomimetics Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Modality:

Blood Transfusion

Bone Marrow Transplant

Pharmacotherapy

By End user:

Hospitals

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Sickle Cell treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Sickle Cell treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Sickle Cell treatment Market, by Treatment Modality, 2019-2027 (USD Billion)
    • 1.2.3. Sickle Cell treatment Market, by End user, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sickle Cell treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sickle Cell treatment Market Dynamics

  • 3.1. Sickle Cell treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing research and development activity
      • 3.1.1.2. Increasing prevalence of sickle cell disease
    • 3.1.2. Market Restraint
      • 3.1.2.1. High cost of treatments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Widespread population of African descent

Chapter 4. Global Sickle Cell treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Sickle Cell treatment Market, by Treatment Modality

  • 5.1. Market Snapshot
  • 5.2. Global Sickle Cell treatment Market by Treatment Modality, Performance - Potential Analysis
  • 5.3. Global Sickle Cell treatment Market Estimates & Forecasts by Treatment modality 2018-2027 (USD Billion)
  • 5.4. Sickle Cell treatment Market , Sub Segment Analysis
    • 5.4.1. Blood Transfusion
    • 5.4.2. Bone Marrow Transplant
    • 5.4.3. Pharmacotherapy

Chapter 6. Global Sickle Cell treatment Market, by End user

  • 6.1. Market Snapshot
  • 6.2. Global Sickle Cell treatment Market by End User, Performance - Potential Analysis
  • 6.3. Global Sickle Cell treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
  • 6.4. Sickle Cell treatment Market , Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Specialty Clinics
    • 6.4.3. Others

Chapter 7. Global Sickle Cell treatment Market, Regional Analysis

  • 7.1. Sickle Cell treatment Market , Regional Market Snapshot
  • 7.2. North America Sickle Cell treatment Market
    • 7.2.1. U.S. Sickle Cell treatment Market
      • 7.2.1.1. Treatment modality breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. End user breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Sickle Cell treatment Market
  • 7.3. Europe Sickle Cell treatment Market Snapshot
    • 7.3.1. U.K. Sickle Cell treatment Market
    • 7.3.2. Germany Sickle Cell treatment Market
    • 7.3.3. France Sickle Cell treatment Market
    • 7.3.4. Spain Sickle Cell treatment Market
    • 7.3.5. Italy Sickle Cell treatment Market
    • 7.3.6. Rest of Europe Sickle Cell treatment Market
  • 7.4. Asia-Pacific Sickle Cell treatment Market Snapshot
    • 7.4.1. China Sickle Cell treatment Market
    • 7.4.2. India Sickle Cell treatment Market
    • 7.4.3. Japan Sickle Cell treatment Market
    • 7.4.4. Australia Sickle Cell treatment Market
    • 7.4.5. South Korea Sickle Cell treatment Market
    • 7.4.6. Rest of Asia Pacific Sickle Cell treatment Market
  • 7.5. Latin America Sickle Cell treatment Market Snapshot
    • 7.5.1. Brazil Sickle Cell treatment Market
    • 7.5.2. Mexico Sickle Cell treatment Market
  • 7.6. Rest of The World Sickle Cell treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Bristol Myers Squibb Co.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Global Blood Therapeutics Inc.
    • 8.2.3. Bluebird Biotechnology
    • 8.2.4. F.Hoffmann-La Roche
    • 8.2.5. Emmaus Medical Inc.
    • 8.2.6. Eli-Lilly and Co.
    • 8.2.7. Baxter Inc.
    • 8.2.8. Medunik USA.Inc.
    • 8.2.9. Addmedica Inc.
    • 8.2.10. Glycomimetics Inc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Sickle Cell treatment Market, report scope
  • TABLE 2. Global Sickle Cell treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Sickle Cell treatment Market estimates & forecasts by Treatment Modality 2018-2027 (USD Billion)
  • TABLE 4. Global Sickle Cell treatment Market estimates & forecasts by End User 2018-2027 (USD Billion)
  • TABLE 5. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Canada Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. UK Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. Germany Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. France Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Spain Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Italy Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. ROE Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. China Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. India Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Japan Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Australia Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. South Korea Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. South Korea Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South KoreaSickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. Brazil Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Mexico Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. ROLA Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROW Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. List of secondary sources used in the study of Global Sickle Cell treatment Market.
  • TABLE 76. List of primary sources used in the study of Global Sickle Cell treatment Market.
  • TABLE 77. Years considered for the study.
  • TABLE 78. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Sickle Cell treatment Market, research methodology
  • FIG 2. Global Sickle Cell treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Sickle Cell treatment Market, key trends 2020
  • FIG 5. Global Sickle Cell treatment Market, growth prospects 2021-2027
  • FIG 6. Global Sickle Cell treatment Market, porters 5 force model
  • FIG 7. Global Sickle Cell treatment Market, pest analysis
  • FIG 8. Global Sickle Cell treatment Market, value chain analysis
  • FIG 9. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Sickle Cell treatment Market, regional snapshot 2018 & 2027
  • FIG 18. North America Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Sickle Cell treatment Market, company market share analysis (2020)